ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ImCheck Therapeutics SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11124
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ImCheck Therapeutics SAS (ImCheck Therapeutics) is an independent biotechnology company that develops drugs for cancer and auto-immune disorders. The company is developing two first-in-class immunomodulator antibodies that are effective against adaptive and innate immunity to treat cancer and other immune related diseases. It works in collaboration with institutions and academics to develop precision & personalized medicines. The company is a spin-off from Marseille’s Institut Paoli-Calmettes. ImCheck Therapeutics is headquartered in Marseille, France.

ImCheck Therapeutics SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImCheck Therapeutics SAS, Medical Devices Deals, 2012 to YTD 2018 9
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
ImCheck Therapeutics Raises USD21.8 Million in Series A Financing 11
Kurma Partners Invests in Imcheck Therapeutics 13
Licensing Agreements 14
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
Equity Offering 15
ImCheck Therapeutics Spin Out from Institut Paoli-Calmettes 15
ImCheck Therapeutics SAS – Key Competitors 16
ImCheck Therapeutics SAS – Key Employees 17
ImCheck Therapeutics SAS – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Sep 12, 2018: Imcheck Therapeutics appoints Prof. Rene Hoet, Phd, as Chief Scientific Officer 19
May 25, 2018: ImCheck Therapeutics Names Dr. Debasish Roychowdhury As Independent Board Chairman 20
May 02, 2017: ImCheck Therapeutics appoints its CEO 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Key Facts 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImCheck Therapeutics SAS, Deals By Therapy Area, 2012 to YTD 2018 8
ImCheck Therapeutics SAS, Medical Devices Deals, 2012 to YTD 2018 9
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ImCheck Therapeutics Raises USD21.8 Million in Series A Financing 11
Kurma Partners Invests in Imcheck Therapeutics 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
ImCheck Therapeutics Spin Out from Institut Paoli-Calmettes 15
ImCheck Therapeutics SAS, Key Competitors 16
ImCheck Therapeutics SAS, Key Employees 17

List of Figures
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ImCheck Therapeutics SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ImCheck Therapeutics SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ImCheck Therapeutics SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ipsen SA (IPN):企業の財務・戦略的SWOT分析
    Ipsen SA (IPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Halliburton Company:企業の戦略・SWOT・財務情報
    Halliburton Company - Strategy, SWOT and Corporate Finance Report Summary Halliburton Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Enbridge Energy Partners LP (EEP):電力:M&Aディール及び事業提携情報
    Summary Enbridge Energy Partners LP (EEP) is a midstream energy partnership that owns and operates a diversified portfolio of crude oil and liquids transportation systems in the US. It provides services through interstate pipeline transportation and storage of crude oil and liquid petroleum. The par …
  • Dexus Property Group:企業のM&A・事業提携・投資動向
    Dexus Property Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dexus Property Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Daybreak Oil and Gas Inc (DBRM):石油・ガス:M&Aディール及び事業提携情報
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • Futuren (FTRN)-エネルギー分野:企業M&A・提携分析
    Summary Futuren, formerly Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The compa …
  • MannKind Corp (MNKD)-製薬・医療分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …
  • Nasdaq Inc (NDAQ):企業の財務・戦略的SWOT分析
    Nasdaq Inc (NDAQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Atlas Elektronik GmbH:企業の戦略・SWOT・財務情報
    Atlas Elektronik GmbH - Strategy, SWOT and Corporate Finance Report Summary Atlas Elektronik GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Toshiba America Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Toshiba America Medical Systems Inc (TAMS), a subsidiary of Toshiba Medical Systems Corp, is a medical device company which markets and distributes the diagnostic imaging systems. The company offers cardiovascular X-ray, computed tomography, angiography, magnetic resonance, ultrasound and x- …
  • Express Scripts Holding Co (ESRX)-製薬・医療分野:企業M&A・提携分析
    Summary Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and m …
  • Basilea Pharmaceutica Ltd (BSLN):企業の財務・戦略的SWOT分析
    Summary Basilea Pharmaceutica Ltd (Basilea) is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company’s products address increasing resistance and non-response to present treatment options for various therapeutic areas such as cancer, bacterial …
  • Mercy Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Mercy Health, formerly Catholic Healthcare Partners, is a Catholic non-profit health system. It operates through a network of hospitals, clinics, medical centers and urgent care facilities in Ohio and Kentucky to offer healthcare services across various specialties. Mercy Health also provide …
  • McWane, Inc.:企業の戦略・SWOT・財務分析
    McWane, Inc. - Strategy, SWOT and Corporate Finance Report Summary McWane, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Khatam al-Anbia:企業の戦略的SWOT分析
    Khatam al-Anbia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Laerdal Medical AS:企業の戦略的SWOT分析
    Laerdal Medical AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Shionogi & Co Ltd (4507):製薬・医療:M&Aディール及び事業提携情報
    Summary Shionogi & Co Ltd (Shionogi) focuses on the research, development, manufacturing and marketing of pharmaceutical products, diagnostic reagents and medical devices. The company's core pharmaceuticals product business offers drugs for the treatment of disorders in the areas of metabolism, infe …
  • The Shipping Corporation of India Ltd (SCI):企業の財務・戦略的SWOT分析
    The Shipping Corporation of India Ltd (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Qatar Airways Group Q.C.S.C.:企業の戦略・SWOT・財務分析
    Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report Summary Qatar Airways Group Q.C.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • OPG Power Ventures Plc (OPG):電力:M&Aディール及び事業提携情報
    Summary OPG Power Ventures Plc (OPG) is an electric utility. It develops, owns, operates, and maintains private sector power projects in India. The company produces electricity from coal source. OPG operates coal-fired power plants in Tamil Nadu and Gujarat. It sells the electricity generated from i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆